(c) 2024 PillSync.com

ARONAMIN GOLD (riboflavin tetrabutyrate 2.5 mg fursultiamine 50 mg hydroxocobalamin acetate 5.22 ug .alpha.-tocopherol acetate 20 mg ascorbic acid 70 mg) Dailymed



IMPRINT: AROG     SHAPE: oval
    COLOR: red

All Imprints

aronamin gold (fursultiamine, riboflavin tetrabutyrate, pyridoxal phosphate, hydroxocobalamin acetate, ascorbic acid, tocopheryl acetate) tablet, film coated - arog oval red

Go PRO for all pill images

Otc - Active Ingredient Section


Fursultiamine(Active vitamin B1) 50.0mg Riboflavin tetrabutyrate(Active vitamin B2) 2.5mg Pyridoxal phosphate(Active vitamin B6) 2.5mg Hydroxocobalamin acetate(Active vitamin B12) 5.22μg Ascorbic acid(Vitamin C) 70mg Tocopheryl acetate(Vitamin E) 20.0mg

Otc - Purpose Section


Vitamines, Mineral & nutrients

Otc - Keep Out Of Reach Of Children Section


Keep out of reach of children

Indications & Usage Section


Adults: take 1 tablet twice a day.

Warnings Section


1) Do not take this medicine.

(1) Patients with hypersensitivity reactions to NSAIDs and the components contained in NSAIDs

(2) Infants under three months of age

(3) Because this drug contains lactose, patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption Do not administer.

2) Do not take the following medicine while taking this medicine.

(1) levodopa

3) Consult a doctor, dentist or pharmacist before taking this medicine.

(1) Patients receiving medical treatment

(2) patients with hyperoxaluria (excessive urinary excretion of urine)

(3) Pregnant women and possibly pregnant women, lactating women, premature infants, infants

(4) Patients with gout or kidney stones

4) Stop taking this drug immediately and consult a doctor, dentist, or pharmacist if you: Whenever possible, bring this attached document with you.

(1) If you have any of the following symptoms

Stomach discomfort, diarrhea, constipation, rash, fever, nausea, vomiting, dilated stool, stomatitis (mouth salt), anorexia, abdominal bloating

(2) Administration of this drug may result in faster or more frequent menstruation, and bleeding may last for a long time.

(3) The risk of thrombosis may be increased if a woman taking an oral contraceptive containing estrogen or a patient with thrombotic placenta is taking vitamin E.

(4) Long-term administration of high doses may result in resistance.

(5) Prolonged use of pyridoxine at a dose of 500 mg to 2 g / day may result in neuropathy or neuropathy (functional disorder or pathologic changes) in the peripheral nervous system.

(6) Hematologic adverse events may occur when vitamin B12 is administered at a dose of 10 μg or more per day in patients with insufficient folic acid.

5) Other Precautions for Taking

(1) Keep the prescribed dosage and dosage.

(2) it may interfere with the detection of blood glucose during various urine tests

(3) The urine may turn yellow, which may affect the clinical examination

6) Storage Precautions

(1) Keep out of the reach of children.

(2) Avoid direct sunlight. Store in a cool, dry place.

(3) To prevent misuse (misuse) and to preserve quality, please do not put in another container.

Inactive Ingredient Section


Microcrystalline Cellulose, Magnesium Stearate, Crospovidone, Copovidone, Colloidal Silicon Dioxide, OY-25014, OY-S-29019

Dosage & Administration Section


For oral use only

Package Label.principal Display Panel




DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site